| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.
|
Virology
|
2002
|
2.55
|
|
2
|
Multiple effects of silymarin on the hepatitis C virus lifecycle.
|
Hepatology
|
2010
|
1.92
|
|
3
|
A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.
|
PLoS One
|
2010
|
1.62
|
|
4
|
Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.
|
J Virol
|
2002
|
1.44
|
|
5
|
Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection.
|
Gastroenterology
|
2009
|
1.40
|
|
6
|
Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.
|
Hepatology
|
2012
|
1.36
|
|
7
|
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
|
PLoS One
|
2011
|
1.27
|
|
8
|
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
|
J Infect Dis
|
2006
|
1.19
|
|
9
|
Expressed gene clusters associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon.
|
J Mol Biol
|
2004
|
1.18
|
|
10
|
Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.
|
J Virol
|
2006
|
1.12
|
|
11
|
Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
|
Hepatology
|
2008
|
1.11
|
|
12
|
Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.
|
J Virol
|
2004
|
1.10
|
|
13
|
Effects of the hepatitis C virus core protein on innate cellular defense pathways.
|
J Interferon Cytokine Res
|
2004
|
1.09
|
|
14
|
Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
|
Virol J
|
2005
|
1.08
|
|
15
|
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.
|
Hepatology
|
2005
|
1.05
|
|
16
|
Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity.
|
Alcohol Clin Exp Res
|
2006
|
1.05
|
|
17
|
Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1.
|
J Gastroenterol Hepatol
|
2010
|
1.03
|
|
18
|
A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control.
|
RNA
|
2010
|
0.98
|
|
19
|
Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.
|
J Virol
|
2013
|
0.98
|
|
20
|
Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking.
|
Cell Microbiol
|
2013
|
0.97
|
|
21
|
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism.
|
J Hepatol
|
2011
|
0.97
|
|
22
|
Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.
|
Clin Cancer Res
|
2013
|
0.96
|
|
23
|
Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
|
J Hepatol
|
2013
|
0.96
|
|
24
|
Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.
|
Biochemistry
|
2007
|
0.96
|
|
25
|
In vitro toxicity assessment of amphiphillic polymer-coated CdSe/ZnS quantum dots in two human liver cell models.
|
ACS Nano
|
2012
|
0.91
|
|
26
|
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.
|
Virol J
|
2006
|
0.89
|
|
27
|
Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
|
J Virol
|
2006
|
0.89
|
|
28
|
Stability of CXCL-8 and related AU-rich mRNAs in the context of hepatitis C virus replication in vitro.
|
J Infect Dis
|
2006
|
0.88
|
|
29
|
Enhanced bioactivity of silybin B methylation products.
|
Bioorg Med Chem
|
2012
|
0.87
|
|
30
|
Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.
|
Hepatology
|
2013
|
0.86
|
|
31
|
Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
|
PLoS One
|
2012
|
0.86
|
|
32
|
Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling.
|
J Nat Prod
|
2015
|
0.83
|
|
33
|
Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems.
|
J Interferon Cytokine Res
|
2002
|
0.83
|
|
34
|
Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle.
|
Bioorg Med Chem
|
2013
|
0.82
|
|
35
|
Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking.
|
Antiviral Res
|
2013
|
0.79
|
|
36
|
Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells.
|
Hepatology
|
2007
|
0.79
|
|
37
|
Antiviral effects of silymarin against hepatitis C: the jury is still out.
|
Hepatology
|
2008
|
0.78
|
|
38
|
HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses.
|
Gastroenterology
|
2009
|
0.77
|
|
39
|
Functional characterization of core genes from patients with acute hepatitis C virus infection.
|
J Infect Dis
|
2010
|
0.76
|
|
40
|
Enantioselective synthesis, stereochemical correction, and biological investigation of the rodgersinine family of 1,4-benzodioxane neolignans.
|
Org Lett
|
2015
|
0.75
|
|
41
|
Detection of hepatitis C virus RNA in normal cervical smears.
|
Clin Infect Dis
|
2003
|
0.75
|
|
42
|
The circulatory orbit of micro-RNAs in hepatitis C.
|
Hepatology
|
2013
|
0.75
|